Immunogenicity and safety of heterologous versus homologous prime-boost schedules with inactivated and adenoviral vectored SARS-CoV-2 vaccines - A prospective multi-center study. - Phuensan P; Sirimongkolkasem J; Tantawichien T; Phannajit J; Kerr SJ; Hansasuta P; Chantharit P; Wongsa A; Fuengfoo P; Chittinandana A; Vareesangthip K; Chayakulkeeree M; et al. (Heliyon, 2023)